 | • レポートコード：QYR9ST05018 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、組換え凝固因子の世界市場について調査・分析し、組換え凝固因子の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組換え第VIII因子、組換え第IX因子、フォンヴィレブランド因子）、用途別（病院、診療所、研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の組換え凝固因子市場動向 ・主要企業別マーケットシェア ・組換え凝固因子の種類別市場規模2014-2019 （組換え第VIII因子、組換え第IX因子、フォンヴィレブランド因子） ・組換え凝固因子の用途別市場規模2014-2019 （病院、診療所、研究機関） ・組換え凝固因子の北米市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子の中国市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子の日本国内市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子の東南アジア市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子のインド市場：主要企業・種類別/用途別市場規模 ・組換え凝固因子の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Baxter International Inc.、Bayer AG、Biogen Idec、CSL Ltd.、Grifols International SA、Kedrion S.P.A.、Novo Nordisk A/S、Octapharma AG、Pfizer Inc.） ・組換え凝固因子の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.In 2018, the global Recombinant Coagulation Factors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Recombinant Coagulation Factors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Coagulation Factors development in United States, Europe and China.
The key players covered in this study
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Market segment by Type, the product can be split into
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor
Market segment by Application, split into
Hospitals
Clinics
Research Organizations
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Recombinant Coagulation Factors status, future forecast, growth opportunity, key market and key players.
To present the Recombinant Coagulation Factors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Recombinant Coagulation Factors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Recombinant Coagulation Factors Market Size Growth Rate by Type (2014-2025)
1.4.2 Recombinant Factor VIII
1.4.3 Recombinant Factor IX
1.4.4 Von Willebrand Factor
1.5 Market by Application
1.5.1 Global Recombinant Coagulation Factors Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Recombinant Coagulation Factors Market Size
2.2 Recombinant Coagulation Factors Growth Trends by Regions
2.2.1 Recombinant Coagulation Factors Market Size by Regions (2014-2025)
2.2.2 Recombinant Coagulation Factors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Recombinant Coagulation Factors Market Size by Manufacturers
3.1.1 Global Recombinant Coagulation Factors Revenue by Manufacturers (2014-2019)
3.1.2 Global Recombinant Coagulation Factors Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Recombinant Coagulation Factors Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Coagulation Factors Key Players Head office and Area Served
3.3 Key Players Recombinant Coagulation Factors Product/Solution/Service
3.4 Date of Enter into Recombinant Coagulation Factors Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Recombinant Coagulation Factors Market Size by Type (2014-2019)
4.2 Global Recombinant Coagulation Factors Market Size by Application (2014-2019)
5 United States
5.1 United States Recombinant Coagulation Factors Market Size (2014-2019)
5.2 Recombinant Coagulation Factors Key Players in United States
5.3 United States Recombinant Coagulation Factors Market Size by Type
5.4 United States Recombinant Coagulation Factors Market Size by Application
6 Europe
6.1 Europe Recombinant Coagulation Factors Market Size (2014-2019)
6.2 Recombinant Coagulation Factors Key Players in Europe
6.3 Europe Recombinant Coagulation Factors Market Size by Type
6.4 Europe Recombinant Coagulation Factors Market Size by Application
7 China
7.1 China Recombinant Coagulation Factors Market Size (2014-2019)
7.2 Recombinant Coagulation Factors Key Players in China
7.3 China Recombinant Coagulation Factors Market Size by Type
7.4 China Recombinant Coagulation Factors Market Size by Application
8 Japan
8.1 Japan Recombinant Coagulation Factors Market Size (2014-2019)
8.2 Recombinant Coagulation Factors Key Players in Japan
8.3 Japan Recombinant Coagulation Factors Market Size by Type
8.4 Japan Recombinant Coagulation Factors Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Recombinant Coagulation Factors Market Size (2014-2019)
9.2 Recombinant Coagulation Factors Key Players in Southeast Asia
9.3 Southeast Asia Recombinant Coagulation Factors Market Size by Type
9.4 Southeast Asia Recombinant Coagulation Factors Market Size by Application
10 India
10.1 India Recombinant Coagulation Factors Market Size (2014-2019)
10.2 Recombinant Coagulation Factors Key Players in India
10.3 India Recombinant Coagulation Factors Market Size by Type
10.4 India Recombinant Coagulation Factors Market Size by Application
11 Central & South America
11.1 Central & South America Recombinant Coagulation Factors Market Size (2014-2019)
11.2 Recombinant Coagulation Factors Key Players in Central & South America
11.3 Central & South America Recombinant Coagulation Factors Market Size by Type
11.4 Central & South America Recombinant Coagulation Factors Market Size by Application
12 International Players Profiles
12.1 Baxter International Inc.
12.1.1 Baxter International Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Recombinant Coagulation Factors Introduction
12.1.4 Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.1.5 Baxter International Inc. Recent Development
12.2 Bayer AG
12.2.1 Bayer AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Recombinant Coagulation Factors Introduction
12.2.4 Bayer AG Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.2.5 Bayer AG Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Recombinant Coagulation Factors Introduction
12.3.4 Biogen Idec Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.3.5 Biogen Idec Recent Development
12.4 CSL Ltd.
12.4.1 CSL Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Recombinant Coagulation Factors Introduction
12.4.4 CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.4.5 CSL Ltd. Recent Development
12.5 Grifols International SA
12.5.1 Grifols International SA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Recombinant Coagulation Factors Introduction
12.5.4 Grifols International SA Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.5.5 Grifols International SA Recent Development
12.6 Kedrion S.P.A.
12.6.1 Kedrion S.P.A. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Recombinant Coagulation Factors Introduction
12.6.4 Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.6.5 Kedrion S.P.A. Recent Development
12.7 Novo Nordisk A/S
12.7.1 Novo Nordisk A/S Company Details
12.7.2 Company Description and Business Overview
12.7.3 Recombinant Coagulation Factors Introduction
12.7.4 Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.7.5 Novo Nordisk A/S Recent Development
12.8 Octapharma AG
12.8.1 Octapharma AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Recombinant Coagulation Factors Introduction
12.8.4 Octapharma AG Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.8.5 Octapharma AG Recent Development
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Recombinant Coagulation Factors Introduction
12.9.4 Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2014-2019)
12.9.5 Pfizer Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Recombinant Coagulation Factors Key Market Segments
Table Key Players Recombinant Coagulation Factors Covered
Table Global Recombinant Coagulation Factors Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Recombinant Coagulation Factors Market Size Market Share by Type 2014-2025
Figure Recombinant Factor VIII Figures
Table Key Players of Recombinant Factor VIII
Figure Recombinant Factor IX Figures
Table Key Players of Recombinant Factor IX
Figure Von Willebrand Factor Figures
Table Key Players of Von Willebrand Factor
Table Global Recombinant Coagulation Factors Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Organizations Case Studies
Figure Recombinant Coagulation Factors Report Years Considered
Table Global Recombinant Coagulation Factors Market Size 2014-2025 (Million US$)
Figure Global Recombinant Coagulation Factors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Recombinant Coagulation Factors Market Size by Regions 2014-2025 (Million US$)
Table Global Recombinant Coagulation Factors Market Size by Regions 2014-2019 (Million US$)
Table Global Recombinant Coagulation Factors Market Share by Regions 2014-2019
Figure Global Recombinant Coagulation Factors Market Share by Regions 2014-2019
Figure Global Recombinant Coagulation Factors Market Share by Regions 2019
Table Market Top Trends
Table Global Recombinant Coagulation Factors Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Recombinant Coagulation Factors Market Share by Manufacturers (2014-2019)
Figure Global Recombinant Coagulation Factors Market Share by Manufacturers in 2018
Table Global Recombinant Coagulation Factors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Recombinant Coagulation Factors Product/Solution/Service
Table Date of Enter into Recombinant Coagulation Factors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table Global Recombinant Coagulation Factors Market Size Share by Type (2014-2019)
Figure Global Recombinant Coagulation Factors Market Size Market Share by Type (2014-2019)
Table Global Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table Global Recombinant Coagulation Factors Market Size Share by Application (2014-2019)
Figure Global Recombinant Coagulation Factors Market Size Market Share by Application (2014-2019)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Application in 2018
Figure United States Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table United States Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table United States Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table United States Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table United States Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table United States Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table United States Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure Europe Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table Europe Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table Europe Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table Europe Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table Europe Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table Europe Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table Europe Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure China Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table China Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table China Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table China Recombinant Coagulation Factors Market Size by Type (2014-20189) (Million US$)
Table China Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table China Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table China Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure Japan Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table Japan Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table Japan Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table Japan Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table Japan Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table Japan Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table Japan Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure Southeast Asia Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table Southeast Asia Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table Southeast Asia Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure India Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table India Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table India Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table India Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table India Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table India Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table India Recombinant Coagulation Factors Market Share by Application (2014-2019)
Figure Central & South America Recombinant Coagulation Factors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Recombinant Coagulation Factors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Recombinant Coagulation Factors Market Share (2018-2019)
Table Central & South America Recombinant Coagulation Factors Market Size by Type (2014-2019) (Million US$)
Table Central & South America Recombinant Coagulation Factors Market Share by Type (2014-2019)
Table Central & South America Recombinant Coagulation Factors Market Size by Application (2014-2019) (Million US$)
Table Central & South America Recombinant Coagulation Factors Market Share by Application (2014-2019)
Table Baxter International Inc. Company Details
Table Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2014-2019) (Million US$)
Figure Baxter International Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Baxter International Inc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Bayer AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Bayer AG Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Biogen Idec Recent Development
Table CSL Ltd. Company Details
Table CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure CSL Ltd. Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table CSL Ltd. Recent Development
Table Grifols International SA Company Details
Table Grifols International SA Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Grifols International SA Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Grifols International SA Recent Development
Table Kedrion S.P.A. Company Details
Table Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Kedrion S.P.A. Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Kedrion S.P.A. Recent Development
Table Novo Nordisk A/S Company Details
Table Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Novo Nordisk A/S Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Novo Nordisk A/S Recent Development
Table Octapharma AG Company Details
Table Octapharma AG Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Octapharma AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Octapharma AG Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2014-2019)(Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Recombinant Coagulation Factors Market Size by Regions (Million US$) 2019-2025
Figure Global Recombinant Coagulation Factors Market Size Share by Regions (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size Share by Regions in 2025
Figure United States Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure China Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure India Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Recombinant Coagulation Factors Market Size Forecast (2019-2025)(Million USD)
Table Global Recombinant Coagulation Factors Market Size by Product (2019-2025) (Million US$)
Figure Global Recombinant Coagulation Factors Market Size by Product (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size by Product in 2025
Table Global Recombinant Coagulation Factors Market Size by Application (2019-2025) (Million US$)
Figure Global Recombinant Coagulation Factors Market Size by Application (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
組換え凝固因子の世界市場：市場規模・現状・予測 Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.In 2018, the global Recombinant Coagulation …- 血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 世界の組換え血漿タンパク質治療薬市場：専門的調査 Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases.Rising demand from Asia-Pacific region is a majo…
- 組換え治療用抗体及びタンパク質の世界市場：インサイト・予測 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…